146
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Elevated TPOAb is a Strong Predictor of Autoimmune Development in Patients of Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Case–Control Study

, , ORCID Icon, , , & show all
Pages 4369-4378 | Published online: 16 Nov 2020

References

  • Cusi K, Sanyal AJ, Zhang S, et al. Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes. Diabetes Obes Metab. 2017;19(11):1630–1634. doi:10.1111/dom.12973
  • Hazim A, Purnamasari D, Kalista K, Lesmana C, Nugroho P. The influence of insulin resistance in the occurrence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes. Diabetes Metab Syndr. 2019;13(2):1431–1435. doi:10.1016/j.dsx.2019.01.058
  • Rhee EJ. Nonalcoholic fatty liver disease and diabetes: an epidemiological perspective. Endocrinol Metab. 2019;34(3):226–233. doi:10.3803/EnM.2019.34.3.226
  • VanWagner LB, Ning H, Allen NB, et al. Twenty-five-year trajectories of insulin resistance and pancreatic beta-cell response and diabetes risk in nonalcoholic fatty liver disease. Liver Int. 2018;38(11):2069–2081.
  • Lee CH, Lam KS. Managing non-alcoholic fatty liver disease in diabetes: challenges and opportunities. J Diabetes Investig. 2017;8(2):131–133. doi:10.1111/jdi.12534
  • Streba LA, Vere CC, Rogoveanu I, Streba CT. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. World J Gastroenterol. 2015;21(14):4103–4110. doi:10.3748/wjg.v21.i14.4103
  • Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2014;59(3):1174–1197. doi:10.1002/hep.26717
  • Bano A, Chaker L, Plompen EP, et al. Thyroid function and the risk of nonalcoholic fatty liver disease: the rotterdam study. J Clin Endocrinol Metab. 2016;101(8):3204–3211. doi:10.1210/jc.2016-1300
  • Chen Y, Wang N, Chen Y, et al. The association of non-alcoholic fatty liver disease with thyroid peroxidase and thyroglobulin antibody: a new insight from SPECT-China study. Autoimmunity. 2018;51(5):238–244. doi:10.1080/08916934.2018.1488968
  • Frohlich E, Wahl R. Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 2017;8:521.
  • Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4–5):391–397. doi:10.1016/j.autrev.2014.01.007
  • Sharifi F, Ghasemi L, Mousavinasab N. Thyroid function and anti-thyroid antibodies in Iranian patients with type 1 diabetes mellitus: influences of age and sex. Iran J Allergy Asthma Immunol. 2008;7(1):31–36.
  • Cardenas Roldan J, Amaya-Amaya J, Castellanos-de la Hoz J. Autoimmune thyroid disease in rheumatoid arthritis: a global perspective. Arthritis. 2012;2012:864907. doi:10.1155/2012/864907
  • Kumar K, Kole AK, Karmakar PS, Ghosh A. The spectrum of thyroid disorders in systemic lupus erythematosus. Rheumatol Int. 2012;32(1):73–78. doi:10.1007/s00296-010-1556-5
  • Al-Khawari M, Shaltout A, Qabazard M, Al-Sane H, Elkum N. Prevalence of thyroid autoantibodies in children, adolescents and young adults with type 1 diabetes in Kuwait. Med Princ Pract. 2015;24(3):280–284. doi:10.1159/000381547
  • Muhame RM, Mworozi EA, McAssey K, Lubega I. Thyroid autoimmunity and function among Ugandan children and adolescents with type-1 diabetes mellitus. Pan Afr Med J. 2014;19:137. doi:10.11604/pamj.2014.19.137.5115
  • Shun CB, Donaghue KC, Phelan H, Twigg SM, Craig ME. Thyroid autoimmunity in type 1 diabetes: systematic review and meta-analysis. Diabet Med. 2014;31(2):126–135.
  • Elebrashy IN, El Meligi A, Rashed L, Salam RF, Youssef E, Fathy SA. Thyroid dysfunction among type 2 diabetic female Egyptian subjects. Ther Clin Risk Manag. 2016;12:1757–1762. doi:10.2147/TCRM.S112302
  • Sarfo-Kantanka O, Sarfo FS, Ansah EO, et al. Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study. BMC Endocr Disord. 2017;17(1):2. doi:10.1186/s12902-016-0152-4
  • Kucera P, Nováková D, Behanová M, Novak J, Tlaskalová-Hogenová H, Andel M. Gliadin, endomysial and thyroid antibodies in patients with latent autoimmune diabetes of adults (LADA). Clin Exp Immunol. 2003;133(1):139–143. doi:10.1046/j.1365-2249.2003.02205.x
  • Adhami M, Michail P, Rao A, et al. Anti-thyroid antibodies and TSH as potential markers of thyroid carcinoma and aggressive behavior in patients with indeterminate fine-needle aspiration cytology. World J Surg. 2019;15(2):203–208.
  • Shi Z, Zhang X, Chen Z, Liebeskind DS, Lou M. Elevated thyroid autoantibodies and intracranial stenosis in stroke at an early age. Int J Stroke. 2014;9(6):735–740. doi:10.1111/ijs.12177
  • Leyhe T, Müssig K. Cognitive and affective dysfunctions in autoimmune thyroiditis. Brain Behav Immun. 2014;41:261–266. doi:10.1016/j.bbi.2014.03.008
  • Tim K, Derakhshan A, Taylor PN. Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta-analysis. JAMA. 2019;322(7):632–641. doi:10.1001/jama.2019.10931
  • Sotak S, Felsoci M, Lazurova I. Type 2 diabetes mellitus and thyroid disease: a two-sided analysis. Bratisl Lek Listy. 2018;119(6):361–365.
  • Díez JJ, Iglesias P. An analysis of the relative risk for hypothyroidism in patients with type 2 diabetes. Diabet Med. 2012;29(12):1510–1514. doi:10.1111/j.1464-5491.2012.03687.x
  • Li Y, Teng D, Ba J, et al. Efficacy and safety of long-term universal salt iodization on thyroid disorders: epidemiological evidence from 31 provinces of mainland China. Thyroid. 2020;30(4):568–579. doi:10.1089/thy.2019.0067
  • Barmpari ME, Kokkorou M, Micheli A, et al. Thyroid dysfunction among greek patients with type 1 and type 2 diabetes mellitus as a disregarded comorbidity. J Diabetes Res. 2017;2017:6505814. doi:10.1155/2017/6505814
  • Fleiner HF, Bjøro T, Midthjell K, Grill V, Åsvold BO. Prevalence of thyroid dysfunction in autoimmune and type 2 diabetes: the population-based HUNT study in Norway. J Clin Endocrinol Metab. 2016;101(2):669–677. doi:10.1210/jc.2015-3235
  • Chaker L, Ligthart S, Korevaar TI, et al. Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study. BMC Med. 2016;14(1):150. doi:10.1186/s12916-016-0693-4
  • Agha-Hosseini F, Shirzad N, Moosavi MS. The association of elevated plasma cortisol and Hashimoto’s Thyroiditis, a neglected part of immune response. Acta Clin Belg. 2016;71(2):81–85. doi:10.1080/17843286.2015.1116152
  • Ballestri S, Romagnoli D, Nascimbeni F, Francica G, Lonardo A. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications. Expert Rev Gastroenterol Hepatol. 2015;9(5):603–627. doi:10.1586/17474124.2015.1007955
  • Vincken S, Reynaert H, Schiettecatte J, Kaufman L, Velkeniers B. Liver cirrhosis and thyroid function: friend or foe? Acta Clin Belg. 2017;72(2):85–90. doi:10.1080/17843286.2016.1215641
  • Manka P, Bechmann L, Best J, et al. Low free triiodothyronine is associated with advanced fibrosis in patients at high risk for nonalcoholic steatohepatitis. Dig Dis Sci. 2019;64(8):2351–2358. doi:10.1007/s10620-019-05687-3
  • Kim D, Kim W, Joo SK, Bae JM, Kim JH, Ahmed A. Subclinical hypothyroidism and low-normal thyroid function are associated with nonalcoholic steatohepatitis and fibrosis. Clin Gastroenterol Hepatol. 2018;16(1):123–131e121. doi:10.1016/j.cgh.2017.08.014